Xin Jie Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xin Jie Chen has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Xiaowen Wang
Department of Biochemistry and Molecular Biology, State University of New York Upstate Medical University
22 shared publicationsLiam P. Coyne
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
8 shared publicationsArnav Rana
Department of Biochemistry and Molecular Biology, State University of New York Upstate Medical University
6 shared publicationsMacMillan Mbantenkhu
Department of Biochemistry and Molecular Biology, State University of New York Upstate Medical University
4 shared publicationsStephan Wilkens
Department of Biochemistry and Molecular Biology, State University of New York Upstate Medical University, Syracuse, New York, USA
4 shared publicationsBlanka Kucejova
Department of Molecular Biology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-9148, USA
3 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 10 (1) , e202603770
Mitochondrial protein import stress augments α-synuclein aggregation and neural damage
Genetic and environmental factors are known to converge on mitochondria to cause Parkinson’s disease. The underlying mechanism is incompletely understood. In addition to bioenergetic defects, nonbioenergetic pathways have been largely unexplored. Validating the nonbioenergetic mitochondrial stressors as independent pathogenic factors is challenging because most mouse models of mitochondrial stress are confounded by bioenergetic defects. Here, we show that expression of Ant1 P.A114P,A123D , previously shown to cause mitochondrial protein import clogging in cultured human cells, does not affect the overall bioenergetic capacity, yet it induces proteostatic stress responses in the cytosol that suggests accumulation of unimported precursor proteins. In a Parkinson’s disease model expressing α-synuclein (A53T), Ant1 P.A114P,A123D increased the size of α-synuclein aggregates, increased aggregation of mitochondrial preproteins, heightened neuroinflammation, and worsened motor coordination defects. Importantly, we found no evidence of bioenergetic defects in either α-synuclein (A53T) or α-synuclein (A53T) + Ant1 P.A114P,A123D mice. These data suggest that Ant1 P.A114P,A123D likely induces mitochondrial protein import stress, and contributes to neural damage through cytosolic proteostatic stress and altered aggregation dynamics of neuropathogenic proteins independent of bioenergetics.
- 10 November 2026
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 10 (1) , e202603770
Open AccessMitochondrial protein import stress augments α-synuclein aggregation and neural damage
Genetic and environmental factors are known to converge on mitochondria to cause Parkinson’s disease. The underlying mechanism is incompletely understood. In addition to bioenergetic defects, nonbioenergetic pathways have been largely unexplored. Validating the nonbioenergetic mitochondrial stressors as independent pathogenic factors is challenging because most mouse models of mitochondrial stress are confounded by bioenergetic defects. Here, we show that expression of Ant1 P.A114P,A123D , previously shown to cause mitochondrial protein import clogging in cultured human cells, does not affect the overall bioenergetic capacity, yet it induces proteostatic stress responses in the cytosol that suggests accumulation of unimported precursor proteins. In a Parkinson’s disease model expressing α-synuclein (A53T), Ant1 P.A114P,A123D increased the size of α-synuclein aggregates, increased aggregation of mitochondrial preproteins, heightened neuroinflammation, and worsened motor coordination defects. Importantly, we found no evidence of bioenergetic defects in either α-synuclein (A53T) or α-synuclein (A53T) + Ant1 P.A114P,A123D mice. These data suggest that Ant1 P.A114P,A123D likely induces mitochondrial protein import stress, and contributes to neural damage through cytosolic proteostatic stress and altered aggregation dynamics of neuropathogenic proteins independent of bioenergetics.
- Open Access
- 22 June 2026
- Published by Annual Reviews in Annual Review of Biochemistry
- Vol. 95 (1) , 401-429
Mitochondrial Precursor Overaccumulation Stress
Damage to mitochondria imparts multifaceted cellular stress that extends beyond bioenergetic deficit. One newly emerged example is mitochondrial precursor overaccumulation stress (mPOS). mPOS is marked by impaired mitochondrial protein import, causing the toxic accumulation and aggregation of unimported mitochondrial precursor proteins in the cytosol. Analogous to the well-studied endoplasmic reticulum stress, which blocks proteins from leaving the cell, mPOS can impose a drastic proteostatic burden in the cytosol and closely interconnects with cell signaling pathways. Here, we review how researchers discovered mPOS and discuss its central importance in several major mitochondria-induced stress signaling pathways. We then focus on the emerging field of mPOS in cell demise and human disease, and we present recent evidence that mPOS can affect cell fitness and survival independent of bioenergetics. Looking forward, mPOS may provide a complementary or alternative pathogenic mechanism to bioenergetic deficit for classic mitochondriopathy and many aging-associated degenerative diseases involving mitochondrial stress.
- 22 June 2026
- Published by Annual Reviews in Annual Review of Biochemistry
- Vol. 95 (1) , 401-429
Open AccessMitochondrial Precursor Overaccumulation Stress
Damage to mitochondria imparts multifaceted cellular stress that extends beyond bioenergetic deficit. One newly emerged example is mitochondrial precursor overaccumulation stress (mPOS). mPOS is marked by impaired mitochondrial protein import, causing the toxic accumulation and aggregation of unimported mitochondrial precursor proteins in the cytosol. Analogous to the well-studied endoplasmic reticulum stress, which blocks proteins from leaving the cell, mPOS can impose a drastic proteostatic burden in the cytosol and closely interconnects with cell signaling pathways. Here, we review how researchers discovered mPOS and discuss its central importance in several major mitochondria-induced stress signaling pathways. We then focus on the emerging field of mPOS in cell demise and human disease, and we present recent evidence that mPOS can affect cell fitness and survival independent of bioenergetics. Looking forward, mPOS may provide a complementary or alternative pathogenic mechanism to bioenergetic deficit for classic mitochondriopathy and many aging-associated degenerative diseases involving mitochondrial stress.
- Open Access
- 27 April 2026
- Published by Springer Nature in EMBO Reports
- Vol. 27 (11) , 2973-3000
Mitochondrial protein import stress causes lysosomal damage and progressive tissue atrophy
Mitochondrial and lysosomal abnormalities co-occur in aging-related diseases with progressive tissue atrophy. It remains unclear whether these two pathogenic pathways affect tissue homeostasis independently, convergently or epistatically. We show that mitochondrial protein import stress causes vacuolar damage in yeast, manifested by V-ATPase disassembly, and vacuolar deacidification and fragmentation. In a mouse model of mitochondrial protein import stress induced by overloading of the nuclear-encoded ANT1 protein, we observe progressive muscle atrophy independent of bioenergetic defects. Like in yeast mutants with severe vacuolar damage, genes involved in amino acid uptake/biosynthesis, one-carbon metabolism, lysosomal biogenesis and iron homeostasis are activated in the skeletal muscle of Ant1 -transgenic mice. The affected muscles accumulate glycogen, lipofuscin and poorly processed multivesicular bodies. Despite activation of lysosomal repair and lysophagic pathways, autophagic flux is severely stalled. During aging, various proteolytic cathepsins are increasingly released from the lysosomal lumen into the cytosol. Together with proteasomal activation, this may contribute to unbalanced proteostasis, reduced myofiber size and skeletal muscle atrophy. Our study therefore discovered an evolutionarily conserved mitochondria-to-lysosome proteotoxic axis that affects tissue mass homeostasis during aging.
- 27 April 2026
- Published by Springer Nature in EMBO Reports
- Vol. 27 (11) , 2973-3000
Open AccessMitochondrial protein import stress causes lysosomal damage and progressive tissue atrophy
Mitochondrial and lysosomal abnormalities co-occur in aging-related diseases with progressive tissue atrophy. It remains unclear whether these two pathogenic pathways affect tissue homeostasis independently, convergently or epistatically. We show that mitochondrial protein import stress causes vacuolar damage in yeast, manifested by V-ATPase disassembly, and vacuolar deacidification and fragmentation. In a mouse model of mitochondrial protein import stress induced by overloading of the nuclear-encoded ANT1 protein, we observe progressive muscle atrophy independent of bioenergetic defects. Like in yeast mutants with severe vacuolar damage, genes involved in amino acid uptake/biosynthesis, one-carbon metabolism, lysosomal biogenesis and iron homeostasis are activated in the skeletal muscle of Ant1 -transgenic mice. The affected muscles accumulate glycogen, lipofuscin and poorly processed multivesicular bodies. Despite activation of lysosomal repair and lysophagic pathways, autophagic flux is severely stalled. During aging, various proteolytic cathepsins are increasingly released from the lysosomal lumen into the cytosol. Together with proteasomal activation, this may contribute to unbalanced proteostasis, reduced myofiber size and skeletal muscle atrophy. Our study therefore discovered an evolutionarily conserved mitochondria-to-lysosome proteotoxic axis that affects tissue mass homeostasis during aging.
- 29 December 2025
- Published by Oxford University Press (OUP) in Genetics
- Vol. 232 (4)
Cellular proteostasis during mitochondrial protein import clogging requires the mitochondrial F-box protein 1 and DJ-1 homolog HSP31 in Saccharomyces cerevisiae
Mitochondrial biogenesis requires the import of ∼1,000 to 1,500 nuclear-encoded proteins across the translocase of outer membrane (TOM) and the translocase of inner membrane (TIM) 22 or 23 complexes. Protein import defects cannot only impair mitochondrial respiration but also cause mitochondrial precursor overaccumulation stress (mPOS) in the cytosol. Recent studies have shown that specific mutations in the nuclear-encoded adenine nucleotide translocase 1 (ANT1) cause musculoskeletal and neurologic diseases by clogging TOM and TIM22 and inducing mPOS. Here, we found that overexpression of MFB1, encoding the mitochondrial F-box protein 1, suppresses cell growth defect caused by a clogger allele of AAC2, the yeast homolog of human Ant1. Disruption of MFB1 synergizes with a clogger allele of aac2 to inhibit cell growth. This is accompanied by increased retention of mitochondrial proteins in the cytosol, suggesting exacerbated defect in mitochondrial protein import. Proximity-dependent biotin identification (BioID) suggested that Mfb1 interacts with several mitochondrial surface proteins including Tom22, a component of the TOM complex. Loss of MFB1 under clogging conditions activates genes encoding cytosolic chaperones including HSP31. Interestingly, disruption of HSP31 creates a synthetic lethality with protein import clogging under respiring conditions. We propose that Mfb1 functions to maintain mitochondrial protein import competency under clogging conditions, whereas Hsp31 plays an important role in protecting the cytosol against mPOS. Mutations in DJ-1, the human homolog of Hsp31, and mitochondria-associated F-box proteins (e.g., Fbxo7) are known to cause early-onset Parkinson's disease. Our work may help to better understand how these mutations affect cellular proteostasis and cause neurodegeneration.
- 29 December 2025
- Published by Oxford University Press (OUP) in Genetics
- Vol. 232 (4)
Cellular proteostasis during mitochondrial protein import clogging requires the mitochondrial F-box protein 1 and DJ-1 homolog HSP31 in Saccharomyces cerevisiae
Mitochondrial biogenesis requires the import of ∼1,000 to 1,500 nuclear-encoded proteins across the translocase of outer membrane (TOM) and the translocase of inner membrane (TIM) 22 or 23 complexes. Protein import defects cannot only impair mitochondrial respiration but also cause mitochondrial precursor overaccumulation stress (mPOS) in the cytosol. Recent studies have shown that specific mutations in the nuclear-encoded adenine nucleotide translocase 1 (ANT1) cause musculoskeletal and neurologic diseases by clogging TOM and TIM22 and inducing mPOS. Here, we found that overexpression of MFB1, encoding the mitochondrial F-box protein 1, suppresses cell growth defect caused by a clogger allele of AAC2, the yeast homolog of human Ant1. Disruption of MFB1 synergizes with a clogger allele of aac2 to inhibit cell growth. This is accompanied by increased retention of mitochondrial proteins in the cytosol, suggesting exacerbated defect in mitochondrial protein import. Proximity-dependent biotin identification (BioID) suggested that Mfb1 interacts with several mitochondrial surface proteins including Tom22, a component of the TOM complex. Loss of MFB1 under clogging conditions activates genes encoding cytosolic chaperones including HSP31. Interestingly, disruption of HSP31 creates a synthetic lethality with protein import clogging under respiring conditions. We propose that Mfb1 functions to maintain mitochondrial protein import competency under clogging conditions, whereas Hsp31 plays an important role in protecting the cytosol against mPOS. Mutations in DJ-1, the human homolog of Hsp31, and mitochondria-associated F-box proteins (e.g., Fbxo7) are known to cause early-onset Parkinson's disease. Our work may help to better understand how these mutations affect cellular proteostasis and cause neurodegeneration.
- Open Access
The Mitochondrial F-box protein 1 and DJ-1 homolog HSP31 support cellular proteostasis during mitochondrial protein import clogging
Mitochondrial biogenesis requires the import of ∼1,000-1,500 nuclear-encoded proteins across the Translocase of Outer Membrane (TOM) and the Translocase of Inner Membrane (TIM) 22 or 23 complexes. Protein import defects cannot only impair mitochondrial respiration but also cause mitochondrial Precursor Overaccumulation Stress (mPOS) in the cytosol. Recent studies showed that specific mutations in the nuclear-encoded Adenine Nucleotide Translocase 1 (ANT1) cause musculoskeletal and neurological diseases by clogging TOM and TIM22 and inducing mPOS. Here, we found that overexpression of MFB1 , encoding the mitochondrial F-box protein 1, suppresses cell growth defect caused by a clogger allele of AAC2 , the yeast homolog of Ant1. Disruption of MFB1 synergizes with a clogger allele of aac2 to inhibit cell growth. This is accompanied by increased retention of mitochondrial proteins in the cytosol, suggesting exacerbated defect in mitochondrial protein import. Proximity-dependent biotin identification (BioID) suggested that Mfb1 interacts with several mitochondrial surface proteins including Tom22, a component of the TOM complex. Loss of MFB1 under clogging conditions activates genes encoding cytosolic chaperones including HSP31 . Interestingly, disruption of HSP31 creates a synthetic lethality with protein import clogging under respiring conditions. We propose that Mfb1 functions to maintain mitochondrial protein import competency under clogging conditions, whereas Hsp31 plays an important role in protecting the cytosol against mPOS. Mutations in DJ-1, the human homolog of Hsp31, and mitochondria-associated F-box proteins (eg., Fbxo7) are known to cause early-onset Parkinson’s disease. Our work may help to better understand how these mutations affect cellular proteostasis and cause neurodegeneration.
Open AccessThe Mitochondrial F-box protein 1 and DJ-1 homolog HSP31 support cellular proteostasis during mitochondrial protein import clogging
Mitochondrial biogenesis requires the import of ∼1,000-1,500 nuclear-encoded proteins across the Translocase of Outer Membrane (TOM) and the Translocase of Inner Membrane (TIM) 22 or 23 complexes. Protein import defects cannot only impair mitochondrial respiration but also cause mitochondrial Precursor Overaccumulation Stress (mPOS) in the cytosol. Recent studies showed that specific mutations in the nuclear-encoded Adenine Nucleotide Translocase 1 (ANT1) cause musculoskeletal and neurological diseases by clogging TOM and TIM22 and inducing mPOS. Here, we found that overexpression of MFB1 , encoding the mitochondrial F-box protein 1, suppresses cell growth defect caused by a clogger allele of AAC2 , the yeast homolog of Ant1. Disruption of MFB1 synergizes with a clogger allele of aac2 to inhibit cell growth. This is accompanied by increased retention of mitochondrial proteins in the cytosol, suggesting exacerbated defect in mitochondrial protein import. Proximity-dependent biotin identification (BioID) suggested that Mfb1 interacts with several mitochondrial surface proteins including Tom22, a component of the TOM complex. Loss of MFB1 under clogging conditions activates genes encoding cytosolic chaperones including HSP31 . Interestingly, disruption of HSP31 creates a synthetic lethality with protein import clogging under respiring conditions. We propose that Mfb1 functions to maintain mitochondrial protein import competency under clogging conditions, whereas Hsp31 plays an important role in protecting the cytosol against mPOS. Mutations in DJ-1, the human homolog of Hsp31, and mitochondria-associated F-box proteins (eg., Fbxo7) are known to cause early-onset Parkinson’s disease. Our work may help to better understand how these mutations affect cellular proteostasis and cause neurodegeneration.
- Open Access
- 18 August 2025
- Published by Springer Nature in Research Square
Mitochondrial protein import stress augments α-synuclein aggregation and neural damage independent of bioenergetics
Genetic and environmental factors are known to converge on mitochondria to cause Parkinson’s disease (PD). However, the mechanisms by which mitochondrial dysfunction contributes to neurodegeneration remain incompletely understood. Non-bioenergetic pathways of the mitochondria are increasingly appreciated, but confounding bioenergetic defects are a major barrier to experimental validation. Here, we show that mild mitochondrial protein import stress augments neural damage independent of bioenergetics. We induce protein import stress in a mouse model of PD expressing α-synuclein(A53T). The double mutant mice demonstrate increased size of α-synuclein aggregates, increased aggregation of mitochondrial preproteins, heightened neuroinflammation and worsened motor defect relative to α-synuclein(A53T) single mutants. Importantly, we found no evidence of bioenergetic defects in any of the mutant mice. These data suggest that mitochondrial protein import stress, which can be induced by many types of mitochondrial injuries, can contribute to neural damage through cytosolic proteostatic stress and possible co-aggregation of mitochondrial and neuropathogenic proteins independent of bioenergetics.
- 18 August 2025
- Published by Springer Nature in Research Square
Open AccessMitochondrial protein import stress augments α-synuclein aggregation and neural damage independent of bioenergetics
Genetic and environmental factors are known to converge on mitochondria to cause Parkinson’s disease (PD). However, the mechanisms by which mitochondrial dysfunction contributes to neurodegeneration remain incompletely understood. Non-bioenergetic pathways of the mitochondria are increasingly appreciated, but confounding bioenergetic defects are a major barrier to experimental validation. Here, we show that mild mitochondrial protein import stress augments neural damage independent of bioenergetics. We induce protein import stress in a mouse model of PD expressing α-synuclein(A53T). The double mutant mice demonstrate increased size of α-synuclein aggregates, increased aggregation of mitochondrial preproteins, heightened neuroinflammation and worsened motor defect relative to α-synuclein(A53T) single mutants. Importantly, we found no evidence of bioenergetic defects in any of the mutant mice. These data suggest that mitochondrial protein import stress, which can be induced by many types of mitochondrial injuries, can contribute to neural damage through cytosolic proteostatic stress and possible co-aggregation of mitochondrial and neuropathogenic proteins independent of bioenergetics.
- 14 July 2023
- Published by Wiley in IUBMB Life
- Vol. 75 (11) , 911-925
Adenine nucleotide carrier protein dysfunction in human disease
Adenine nucleotide translocase (ANT) is the prototypical member of the mitochondrial carrier protein family, primarily involved in ADP/ATP exchange across the inner mitochondrial membrane. Several carrier proteins evolutionarily related to ANT, including SLC25A24 and SLC25A25, are believed to promote the exchange of cytosolic ATP‐Mg2+ with phosphate in the mitochondrial matrix. They allow a net accumulation of adenine nucleotides inside mitochondria, which is essential for mitochondrial biogenesis and cell growth. In the last two decades, mutations in the heart/muscle isoform 1 of ANT (ANT1) and the ATP‐Mg2+ transporters have been found to cause a wide spectrum of human diseases by a recessive or dominant mechanism. Although loss‐of‐function recessive mutations cause a defect in oxidative phosphorylation and an increase in oxidative stress which drives the pathology, it is unclear how the dominant missense mutations in these proteins cause human diseases. In this review, we focus on how yeast was productively used as a model system for the understanding of these dominant diseases. We also describe the relationship between the structure and function of ANT and how this may relate to various pathologies. Particularly, mutations in Aac2, the yeast homolog of ANT, were recently found to clog the mitochondrial protein import pathway. This leads to mitochondrial precursor overaccumulation stress (mPOS), characterized by the toxic accumulation of unimported mitochondrial proteins in the cytosol. We anticipate that in coming years, yeast will continue to serve as a useful model system for the mechanistic understanding of mitochondrial protein import clogging and related pathologies in humans.
- 14 July 2023
- Published by Wiley in IUBMB Life
- Vol. 75 (11) , 911-925
Adenine nucleotide carrier protein dysfunction in human disease
Adenine nucleotide translocase (ANT) is the prototypical member of the mitochondrial carrier protein family, primarily involved in ADP/ATP exchange across the inner mitochondrial membrane. Several carrier proteins evolutionarily related to ANT, including SLC25A24 and SLC25A25, are believed to promote the exchange of cytosolic ATP‐Mg2+ with phosphate in the mitochondrial matrix. They allow a net accumulation of adenine nucleotides inside mitochondria, which is essential for mitochondrial biogenesis and cell growth. In the last two decades, mutations in the heart/muscle isoform 1 of ANT (ANT1) and the ATP‐Mg2+ transporters have been found to cause a wide spectrum of human diseases by a recessive or dominant mechanism. Although loss‐of‐function recessive mutations cause a defect in oxidative phosphorylation and an increase in oxidative stress which drives the pathology, it is unclear how the dominant missense mutations in these proteins cause human diseases. In this review, we focus on how yeast was productively used as a model system for the understanding of these dominant diseases. We also describe the relationship between the structure and function of ANT and how this may relate to various pathologies. Particularly, mutations in Aac2, the yeast homolog of ANT, were recently found to clog the mitochondrial protein import pathway. This leads to mitochondrial precursor overaccumulation stress (mPOS), characterized by the toxic accumulation of unimported mitochondrial proteins in the cytosol. We anticipate that in coming years, yeast will continue to serve as a useful model system for the mechanistic understanding of mitochondrial protein import clogging and related pathologies in humans.
- Open Access
- 2 May 2023
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Mitochondrial protein import clogging as a mechanism of disease
Mitochondrial biogenesis requires the import of >1,000 mitochondrial preproteins from the cytosol. Most studies on mitochondrial protein import are focused on the core import machinery. Whether and how the biophysical properties of substrate preproteins affect overall import efficiency is underexplored. Here, we show that protein traffic into mitochondria can be disrupted by amino acid substitutions in a single substrate preprotein. Pathogenic missense mutations in ADP/ATP translocase 1 (ANT1), and its yeast homolog ADP/ATP carrier 2 (Aac2), cause the protein to accumulate along the protein import pathway, thereby obstructing general protein translocation into mitochondria. This impairs mitochondrial respiration, cytosolic proteostasis, and cell viability independent of ANT1’s nucleotide transport activity. The mutations act synergistically, as double mutant Aac2/ANT1 causes severe clogging primarily at the translocase of the outer membrane (TOM) complex. This confers extreme toxicity in yeast. In mice, expression of a super-clogger ANT1 variant led to neurodegeneration and an age-dependent dominant myopathy that phenocopy ANT1-induced human disease, suggesting clogging as a mechanism of disease. More broadly, this work implies the existence of uncharacterized amino acid requirements for mitochondrial carrier proteins to avoid clogging and subsequent disease.
- 2 May 2023
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Open AccessMitochondrial protein import clogging as a mechanism of disease
Mitochondrial biogenesis requires the import of >1,000 mitochondrial preproteins from the cytosol. Most studies on mitochondrial protein import are focused on the core import machinery. Whether and how the biophysical properties of substrate preproteins affect overall import efficiency is underexplored. Here, we show that protein traffic into mitochondria can be disrupted by amino acid substitutions in a single substrate preprotein. Pathogenic missense mutations in ADP/ATP translocase 1 (ANT1), and its yeast homolog ADP/ATP carrier 2 (Aac2), cause the protein to accumulate along the protein import pathway, thereby obstructing general protein translocation into mitochondria. This impairs mitochondrial respiration, cytosolic proteostasis, and cell viability independent of ANT1’s nucleotide transport activity. The mutations act synergistically, as double mutant Aac2/ANT1 causes severe clogging primarily at the translocase of the outer membrane (TOM) complex. This confers extreme toxicity in yeast. In mice, expression of a super-clogger ANT1 variant led to neurodegeneration and an age-dependent dominant myopathy that phenocopy ANT1-induced human disease, suggesting clogging as a mechanism of disease. More broadly, this work implies the existence of uncharacterized amino acid requirements for mitochondrial carrier proteins to avoid clogging and subsequent disease.
- Open Access
Mitochondrial protein import clogging as a mechanism of disease
Mitochondrial biogenesis requires the import of >1,000 mitochondrial preproteins from the cytosol. Most studies on mitochondrial protein import are focused on the core import machinery. Whether and how the biophysical properties of substrate preproteins affect overall import efficiency is underexplored. Here, we show that protein traffic into mitochondria is disrupted by amino acid substitutions in a single substrate preprotein. Pathogenic missense mutations in adenine nucleotide translocase 1 (Ant1), and its yeast ortholog Aac2, cause the protein to accumulate along the protein import pathway, thereby obstructing general protein translocation into mitochondria. This impairs mitochondrial respiration, cytosolic proteostasis and cell viability independent of Ant1’s nucleotide transport activity. The mutations act synergistically, as double mutant Aac2/Ant1 cause severe clogging primarily at the Translocase of the Outer Membrane (TOM) complex. This confers extreme toxicity in yeast. In mice, expression of a super-clogger Ant1 variant led to an age-dependent dominant myopathy that phenocopies Ant1-induced human disease, suggesting clogging as a mechanism of disease. We propose that secondary structures of mitochondrial preproteins play an essential role in preventing clogging and disease.
Open AccessMitochondrial protein import clogging as a mechanism of disease
Mitochondrial biogenesis requires the import of >1,000 mitochondrial preproteins from the cytosol. Most studies on mitochondrial protein import are focused on the core import machinery. Whether and how the biophysical properties of substrate preproteins affect overall import efficiency is underexplored. Here, we show that protein traffic into mitochondria is disrupted by amino acid substitutions in a single substrate preprotein. Pathogenic missense mutations in adenine nucleotide translocase 1 (Ant1), and its yeast ortholog Aac2, cause the protein to accumulate along the protein import pathway, thereby obstructing general protein translocation into mitochondria. This impairs mitochondrial respiration, cytosolic proteostasis and cell viability independent of Ant1’s nucleotide transport activity. The mutations act synergistically, as double mutant Aac2/Ant1 cause severe clogging primarily at the Translocase of the Outer Membrane (TOM) complex. This confers extreme toxicity in yeast. In mice, expression of a super-clogger Ant1 variant led to an age-dependent dominant myopathy that phenocopies Ant1-induced human disease, suggesting clogging as a mechanism of disease. We propose that secondary structures of mitochondrial preproteins play an essential role in preventing clogging and disease.
- Open Access
Mitochondrial protein import stress augments α-synuclein aggregation and neurodegeneration independent of bioenergetics
Mitochondrial biogenesis depends on the import of cytosolically synthesized proteins, and many pathophysiological conditions are expected to reduce protein import. However, despite severe mitochondrial protein import defects concomitant with impaired oxidative phosphorylation being implicated in ultra-rare neurodegenerative diseases, the neurological effects specific to protein import stress are unknown due to lack of an adequate animal model. Here, we fill this gap using our recently established protein import “clogger” mouse model, which expresses mutant adenine nucleotide translocase 1 (Ant1) that clogs the mitochondrial protein import machinery. While a small fraction of clogger mice undergo paralytic neurodegeneration, we show that non-paralytic mice do not have bioenergetic defects in the central nervous system. Non-paralytic clogger mice actually perform better than wild-type in behavioral assays of motor coordination and executive function. Transcriptomic analysis revealed signaling pathways directed towards counteracting proteotoxicity, possibly as a response to the accumulation of mitochondrial preproteins in the cytosol, a process known as mitochondrial Precursor Overaccumulation Stress (mPOS). IGF-2 was robustly upregulated in the spinal cord. IGF-2 is known to play a role in the extrusion of cytosolic protein aggregates into the extracellular space, in addition to its primary role in cell growth and development. To provide further support for a role of protein import stress in neurodegeneration, we crossed the clogger mice with a mouse model of Parkinson’s disease expressing a cytosolic aggregation-prone protein, α-synucleinA53T. We found that mild protein import stress significantly worsens motor coordination in α-synucleinA53T, but not wild-type mice. In addition, double mutant mice showed modestly shortened maximal lifespan compared with α-synucleinA53T animals. We found no evidence of impaired bioenergetics in the double mutant mice. These findings suggest that mild protein import stress can modify neurodegeneration independent of bioenergetics. Future work is required to establish whether this occurs by enhancing cytosolic protein aggregation via mPOS.
Open AccessMitochondrial protein import stress augments α-synuclein aggregation and neurodegeneration independent of bioenergetics
Mitochondrial biogenesis depends on the import of cytosolically synthesized proteins, and many pathophysiological conditions are expected to reduce protein import. However, despite severe mitochondrial protein import defects concomitant with impaired oxidative phosphorylation being implicated in ultra-rare neurodegenerative diseases, the neurological effects specific to protein import stress are unknown due to lack of an adequate animal model. Here, we fill this gap using our recently established protein import “clogger” mouse model, which expresses mutant adenine nucleotide translocase 1 (Ant1) that clogs the mitochondrial protein import machinery. While a small fraction of clogger mice undergo paralytic neurodegeneration, we show that non-paralytic mice do not have bioenergetic defects in the central nervous system. Non-paralytic clogger mice actually perform better than wild-type in behavioral assays of motor coordination and executive function. Transcriptomic analysis revealed signaling pathways directed towards counteracting proteotoxicity, possibly as a response to the accumulation of mitochondrial preproteins in the cytosol, a process known as mitochondrial Precursor Overaccumulation Stress (mPOS). IGF-2 was robustly upregulated in the spinal cord. IGF-2 is known to play a role in the extrusion of cytosolic protein aggregates into the extracellular space, in addition to its primary role in cell growth and development. To provide further support for a role of protein import stress in neurodegeneration, we crossed the clogger mice with a mouse model of Parkinson’s disease expressing a cytosolic aggregation-prone protein, α-synucleinA53T. We found that mild protein import stress significantly worsens motor coordination in α-synucleinA53T, but not wild-type mice. In addition, double mutant mice showed modestly shortened maximal lifespan compared with α-synucleinA53T animals. We found no evidence of impaired bioenergetics in the double mutant mice. These findings suggest that mild protein import stress can modify neurodegeneration independent of bioenergetics. Future work is required to establish whether this occurs by enhancing cytosolic protein aggregation via mPOS.